Alice Gaudin holds a PhD in the field of Biomedical Engineering and Neurosciences from the University Paris-Sud XI. She supplemented her degree with two years of postdoctoral experience at the Department of Biomedical Engineering at Yale University, developing nanoparticles for the treatment of glioblastoma multiforme. These experiences allowed. Alice to develop a significant expertise in the field of drug delivery for applications in oncology and neurosciences. Alice joined IPSEN Innovation in early 2017 in the Early and Novel Formulation Technologies team, to oversee the evaluation and the implementation of new formulation technologies for molecules at early stage, and to investigate new innovative galenic forms and/or administration routes as opportunities of life-cycle management.
